Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allied Minds Names Joseph Pignato as CFO

1 Sep 2015 07:03

RNS Number : 5800X
Allied Minds PLC
01 September 2015
 



Allied Minds Names Joseph Pignato as Chief Financial Officer

 

· Joe has served as a senior advisor to fast-growing businesses for almost two decades, and brings a wide range of experience working with venture capital firms as well as start-up and publicly traded companies.

 

· Joe was most recently CFO of Swipely, where he helped oversee growth in sales under management to more than $4 billion. He also served in senior management positions at Charles River Ventures, Prism Ventures and Lightbridge.

 

 

Boston (September 01, 2015) - Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company, today announced that Joseph Pignato is joining its executive management team as Chief Financial Officer.

 

Joe's experience as a senior advisor to fast-growing businesses spans almost two decades. After gaining experience in accounting at PKF Worldwide and Deloitte, Joe developed expertise in the effective deployment of venture capital for early stage companies during his tenure as CFO of Charles River Ventures; as General Partner, Chief Operating Officer and CFO of Prism Ventures; and as a Board Member of the Slater Technology Fund. Joe also applied his own skills in value creation while serving as Director of Finance at Lightbridge, a NASDAQ-listed firm that he helped to take public; and as CFO at Swipely, which grew to more than $4 billion in sales under management during his tenure.

 

"It's a privilege to join Allied Minds, a company that brings together a unique mix of entrepreneurial talent and seasoned, global expertise," said Joe. "Allied Minds' dynamic and fast-moving environment is exciting, and I look forward to working with the team to help develop and support new companies in their innovative, and potentially market-disruptive, work."

 

Joe's broad strengths in finance, investor relations and operations, as well as his skills as a mentor to management teams, will be an asset to Allied Minds and its 22 subsidiary companies. At Allied Minds, Joe is joining an expanding team of experienced senior managers who are engaged in advising the portfolio companies on how to navigate high-growth strategies as they commercialize sophisticated technologies developed at U.S. federal and academic research centers.

 

"Joe brings a robust track record of managing and fostering early stage companies into financial stability and growth," said Chris Silva, Chief Executive Officer of Allied Minds. "I am confident that he will further enhance our ability to transform U.S. inventions into commercial innovation. We are delighted to have him on board the Allied Minds team."

 

More information about Allied Minds can be found at www.alliedminds.com

 

Media Contact:

 

US

Christine Dunn

ArcPoint Strategic Communications

cdunn@arcpointstrategy.com

617.484.1660 x101

 

UK

Ben Atwell / Matthew Cole

FTI Consulting

+44 (0) 20 3727 1000

 

About Allied Minds, Inc.

Allied Minds is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com.

 

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risk and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Prospectus Rules, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

###

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKDDDOBKDOFN
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.